Literature DB >> 26432712

[Update peripheral arterial occlusive disease].

E Blessing1.   

Abstract

Due to demographic changes, peripheral arterial occlusive disease (PAD) has become one of the most prevalent diseases in western industrial nations. In recent years the trend towards initial endovascular treatment approaches has further continued. Because of the high primary success and low complication rates, intervention-based revascularization strategies are the method of choice in the majority of cases. The treatment strategy should always be assessed in a multidisciplinary setting and if possible, within a designated vascular center. One of the main limitations of interventions is the occurrence of restenosis, in particular in infrapopliteal arterial lesions. A major progress arose from drug-eluting balloons, which dramatically reduced restenosis rates particular for femoropopliteal lesions. A potential alternative strategy could be the use of a combination therapy, such as plaque removal followed by insertion of drug-eluting balloons; however, economic issues have to be kept in mind for such approaches.

Entities:  

Keywords:  Atherosclerosis; Coronary intervention; Intermittent claudication; Ischemia; Preventive measures

Mesh:

Year:  2015        PMID: 26432712     DOI: 10.1007/s00059-015-4357-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  48 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training--randomized controlled trial.

Authors:  Sandra Spronk; Johanna L Bosch; Pieter T den Hoed; Hermanus F Veen; Peter M T Pattynama; M G Myriam Hunink
Journal:  Radiology       Date:  2009-02       Impact factor: 11.105

3.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

Review 4.  Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials.

Authors:  Massimiliano Fusaro; Salvatore Cassese; Gjin Ndrepepa; Gunnar Tepe; Lamin King; Ilka Ott; Mateja Nerad; Heribert Schunkert; Adnan Kastrati
Journal:  JACC Cardiovasc Interv       Date:  2013-12       Impact factor: 11.195

5.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

6.  Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial.

Authors:  Aljoscha Rastan; Hans Krankenberg; Iris Baumgartner; Erwin Blessing; Stefan Müller-Hülsbeck; Ernst Pilger; Dierk Scheinert; Johannes Lammer; Ulrich Beschorner; Elias Noory; Franz-Josef Neumann; Thomas Zeller
Journal:  J Endovasc Ther       Date:  2015-02       Impact factor: 3.487

7.  Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions.

Authors:  James F McKinsey; Lee Goldstein; Habib U Khan; Ashley Graham; Combiz Rezeyat; Nicholas J Morrissey; Elliott Sambol; K Craig Kent
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

8.  Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.

Authors:  Thomas Zeller; Iris Baumgartner; Dierk Scheinert; Marianne Brodmann; Marc Bosiers; Antonio Micari; Patrick Peeters; Frank Vermassen; Mario Landini; David B Snead; K Craig Kent; Krishna J Rocha-Singh
Journal:  J Am Coll Cardiol       Date:  2014-10-14       Impact factor: 24.094

9.  Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials.

Authors:  Salvatore Cassese; Robert A Byrne; Ilka Ott; Gjin Ndrepepa; Mateja Nerad; Adnan Kastrati; Massimiliano Fusaro
Journal:  Circ Cardiovasc Interv       Date:  2012-07-31       Impact factor: 6.546

10.  Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.

Authors:  Gunnar Tepe; John Laird; Peter Schneider; Marianne Brodmann; Prakash Krishnan; Antonio Micari; Christopher Metzger; Dierk Scheinert; Thomas Zeller; David J Cohen; David B Snead; Beaux Alexander; Mario Landini; Michael R Jaff
Journal:  Circulation       Date:  2014-12-03       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.